Published in Urology on June 01, 2006
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol (2011) 2.22
Tumour location as a predictor of benign disease in the management of renal masses. Can Urol Assoc J (2010) 1.49
External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery. World J Urol (2010) 1.08
Renal masses herniating into the hilum: technical considerations of the "ball-valve phenomenon" during nephron-sparing surgery. Urology (2009) 0.96
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging (2015) 0.87
Active surveillance of small renal masses. Nat Rev Urol (2013) 0.86
A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy. Rev Urol (2011) 0.82
Efficacy of parenchymal compression in open partial nephrectomies: a comparison with conventional vascular clamping. Korean J Urol (2010) 0.80
Diagnostic significance of biopsies in renal masses. Cent European J Urol (2014) 0.80
Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer. Biologics (2012) 0.80
Laparoscopic partial nephrectomy: Technical considerations and an update. J Minim Access Surg (2011) 0.80
Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis. Urol Oncol (2014) 0.79
Cryoablation for endophytic renal cell carcinoma: intermediate-term oncologic efficacy and safety. Korean J Urol (2010) 0.79
Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesions. Urol Oncol (2014) 0.78
Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences. World J Surg Oncol (2014) 0.78
Is anatomic complexity associated with renal tumor growth kinetics under active surveillance? Urol Oncol (2015) 0.77
A matched-cohort comparison of laparoscopic renal cryoablation using ultra-thin cryoprobes with open partial nephrectomy for the treatment of small renal cell carcinoma. Cancer Res Treat (2008) 0.76
Efficacy of laparoscopic renal cryoablation as an alternative treatment for small renal mass in patients with poor operability: experience from the Korean single center. J Laparoendosc Adv Surg Tech A (2010) 0.76
Renal cryoablation of small renal masses: a Korea University experience. Korean J Urol (2015) 0.75
Mini-flank supra-12th rib incision for open partial nephrectomy for renal tumor with RENAL nephrometry score ≥10: an innovation of traditional open surgery. Medicine (Baltimore) (2015) 0.75
Retroperitoneal laparoscopic renal tumour enucleation with local hypotension on demand. World J Urol (2014) 0.75
Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol (2010) 4.84
Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: initial experience with laparoscopic radical prostatectomy. J Urol (2003) 3.93
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol (2009) 3.59
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int (2008) 3.51
A framework for the identification of men at increased risk for prostate cancer. J Urol (2009) 3.07
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial. J Urol (2005) 3.01
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51
Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst (2006) 2.48
PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial. J Urol (2010) 2.33
Technique for laparoscopic running urethrovesical anastomosis:the single knot method. Urology (2003) 2.26
Preoperative warming up exercises improve laparoscopic operative times in an experienced laparoscopic surgeon. J Endourol (2012) 2.26
Comparison of hand assisted and standard laparoscopic radical nephroureterectomy for the management of localized transitional cell carcinoma. J Urol (2002) 2.23
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev (2009) 2.20
Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol (2006) 2.17
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med (2003) 2.16
Development and initial porcine and cadaver experience with three-dimensional printing of endoscopic and laparoscopic equipment. J Endourol (2015) 2.08
BioGlue iceball stabilization to minimize the risk of hemorrhage during laparoscopic renal cryoablation. Urology (2011) 2.07
Long-term followup after laparoscopic radical nephrectomy. J Urol (2002) 2.07
Feasibility of omitting cortical renorrhaphy during robot-assisted partial nephrectomy: a matched analysis. J Endourol (2015) 2.05
Nomenclature of natural orifice translumenal endoscopic surgery (NOTES) and laparoendoscopic single-site surgery (LESS) procedures in urology. J Endourol (2008) 1.97
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81
Endoscopically guided percutaneous renal access: "seeing is believing". J Endourol (2006) 1.81
Percutaneous and laparoscopic cryoablation of small renal masses. J Urol (2008) 1.80
Current management of urolithiasis: progress or regress? J Endourol (2002) 1.74
RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate (2007) 1.74
Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction. J Endourol (2010) 1.72
Determination of patient concerns in choosing surgery and preference for laparoendoscopic single-site surgery and assessment of satisfaction with postoperative cosmesis. J Endourol (2011) 1.67
Comparison of guide wires in urology. Which, when and why? J Urol (2004) 1.67
Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer (2013) 1.66
Risk-based prostate cancer screening. Eur Urol (2011) 1.64
Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE Study. Cancer Epidemiol Biomarkers Prev (2012) 1.63
The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. J Urol (2006) 1.63
A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res (2005) 1.63
11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction. J Nucl Med (2013) 1.60
Validating the use of the Mimic dV-trainer for robotic surgery skill acquisition among urology residents. Urology (2011) 1.58
Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years. Urology (2010) 1.58
Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. Urology (2010) 1.57
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
The role of R.E.N.A.L. nephrometry score in the era of robot-assisted partial nephrectomy. J Endourol (2013) 1.55
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study. BJU Int (2011) 1.54
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol (2009) 1.53
Laparoendoscopic single-site surgery for nephrectomy as a feasible alternative to traditional laparoscopy. Urology (2009) 1.52
Low-dose and standard computed tomography scans yield equivalent stone measurements. Urology (2013) 1.52
Proactive medicine: the "UCI 30," an ultrasound-based clinical initiative from the University of California, Irvine. Acad Med (2014) 1.49
R.E.N.A.L. nephrometry score accurately predicts complications following laparoscopic renal cryoablation. J Urol (2012) 1.49
Consensus statement on natural orifice transluminal endoscopic surgery and single-incision laparoscopic surgery: heralding a new era in urology? Eur Urol (2008) 1.48
Use of a warming bath to prevent lens fogging during laparoscopy. J Endourol (2008) 1.47
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA (2011) 1.46
Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology (2007) 1.46
Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial. Urology (2009) 1.45
Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy? Urology (2013) 1.45
Use of gelatin matrix to rapidly repair diaphragmatic injury during laparoscopy. Urology (2002) 1.45
Laparoscopic live-donor nephrectomy. BJU Int (2006) 1.44
Evaluation of perirenal fat as a predictor of cT 1a renal cortical neoplasm histopathology and surgical outcomes. J Endourol (2012) 1.44
Biopsy misidentification identified by DNA profiling in a large multicenter trial. J Clin Oncol (2011) 1.44
Pathological confirmation of nerve-sparing types performed during robot-assisted radical prostatectomy (RARP). BJU Int (2012) 1.43
Differentiating reconstructive techniques in partial nephrectomy: a propensity score analysis. Can J Urol (2015) 1.42
Three-Dimensional (3D) Vision: Does It Improve Laparoscopic Skills? An Assessment of a 3D Head-Mounted Visualization System. Rev Urol (2005) 1.41
Bare naked baskets: optimizing ureteroscopic stone extraction. Urology (2002) 1.41
Bare naked baskets: ureteroscope deflection and flow characteristics with intact and disassembled ureteroscopic nitinol stone baskets. J Urol (2002) 1.40
Risk factors associated with 30 day hospital readmission following partial nephrectomy. Can J Urol (2015) 1.40
The impact of hospital volume on postoperative complications following robot-assisted partial nephrectomy. J Endourol (2014) 1.40
Evaluation of bladder insufflants for transurethral cryoablation of the bladder. Urology (2009) 1.40
Best practices for robotic surgery training and credentialing. J Urol (2011) 1.40
Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol (2010) 1.40
Pure laparoscopic radical heminephrectomy and partial isthmusectomy for renal cell carcinoma in a horseshoe kidney: case report and technical considerations. Urology (2005) 1.39
Survey of residency training in laparoscopic and robotic surgery. J Urol (2006) 1.39
Impact of ischemia on renal function after laparoscopic partial nephrectomy: a multicenter study. J Urol (2010) 1.38
Construct validity testing of a laparoscopic surgical simulator. J Am Coll Surg (2006) 1.32
Benign prostatic hyperplasia: a progressive disease of aging men. Urology (2003) 1.31
Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2007) 1.30
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst (2010) 1.29
Durability of flexible ureteroscopes: a randomized, prospective study. J Urol (2006) 1.29
2D versus 3D visualization: impact on laparoscopic proficiency using the fundamentals of laparoscopic surgery skill set. J Laparoendosc Adv Surg Tech A (2012) 1.29
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst (2012) 1.27
Robotic versus standard laparoscopic partial/wedge nephrectomy: a comparison of intraoperative and perioperative results from a single institution. J Endourol (2008) 1.26
Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction. J Urol (2003) 1.26
Preliminary study of virtual reality and model simulation for learning laparoscopic suturing skills. J Urol (2009) 1.25
Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease. J Urol (2007) 1.24
Prostate cancer screening: current status and future perspectives. Nat Rev Urol (2010) 1.23